Adaptive Biotechnologies Corp
NASDAQ:ADPT

Watchlist Manager
Adaptive Biotechnologies Corp Logo
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Watchlist
Price: 9.31 USD 1.75% Market Closed
Market Cap: 1.4B USD

Wall Street
Price Targets

ADPT Price Targets Summary
Adaptive Biotechnologies Corp

Wall Street analysts forecast ADPT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ADPT is 11.56 USD with a low forecast of 9.09 USD and a high forecast of 13.65 USD.

Lowest
Price Target
9.09 USD
2% Downside
Average
Price Target
11.56 USD
24% Upside
Highest
Price Target
13.65 USD
47% Upside
Adaptive Biotechnologies Corp Competitors:
Price Targets
EVT
Evotec SE
90% Upside
MTD
Mettler-Toledo International Inc
11% Upside
688046
GemPharmatech Co Ltd
64% Upside
300463
Maccura Biotechnology Co Ltd
17% Upside
DXRX
Diaceutics PLC
48% Upside
TECN
Tecan Group AG
34% Upside
RVU
Ryvu Therapeutics SA
148% Upside
TMO
Thermo Fisher Scientific Inc
43% Upside

Revenue
Forecast

Revenue Estimate
Adaptive Biotechnologies Corp

For the last 6 years the compound annual growth rate for Adaptive Biotechnologies Corp's revenue is 21%. The projected CAGR for the next 3 years is 23%.

21%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Adaptive Biotechnologies Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Adaptive Biotechnologies Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ADPT's stock price target?
Price Target
11.56 USD

According to Wall Street analysts, the average 1-year price target for ADPT is 11.56 USD with a low forecast of 9.09 USD and a high forecast of 13.65 USD.

What is Adaptive Biotechnologies Corp's Revenue forecast?
Projected CAGR
23%

For the last 6 years the compound annual growth rate for Adaptive Biotechnologies Corp's revenue is 21%. The projected CAGR for the next 3 years is 23%.

Back to Top